C. R. Bard, Inc.
C. R. Bard, Inc. Web Site
Back to Directory   


 
  Archived News

This portion of our Web site contains archival information. Archived information contained or referenced herein should not be considered current and may no longer be accurate.

TITLE DATE
Bard Declares Quarterly Dividend 8-Dec-2010
Bard to Host December 2010 Investor Conference 4-Nov-2010
Bard Announces Third Quarter Results Diluted EPS of $1.34, $1.43 on Adjusted Basis 21-Oct-2010
Bard to Host Earnings Conference Call on October 21, 2010 14-Oct-2010
Bard Declares Quarterly Dividend 13-Oct-2010
Bard Announces Second Quarter Results 22-Jul-2010
Bard to Host Earnings Conference Call on July 22, 2010 15-Jul-2010
Bard Closes Transaction to Acquire SenoRx, Inc. 6-Jul-2010
Bard Announces $500 Million Share Repurchase Authorization 9-Jun-2010
Bard Increases Quarterly Dividend 9-Jun-2010
Bard Announces Agreement to Acquire SenoRx, Inc. 5-May-2010
Bard Announces First Quarter Results 22-Apr-2010
Bard Declares Quarterly Dividend 21-Apr-2010
Bard to Host Earnings Conference Call on April 22, 2010 15-Apr-2010
NEJM Publishes Trial Results Demonstrating Bard FLAIR(R) Endovascular Stent Graft is Superior to Balloon Angioplasty for Failing Dialysis Grafts 10-Feb-2010
Bard Announces Fourth Quarter Results 28-Jan-2010
Bard to Host Earnings Conference Call on January 28, 2010 21-Jan-2010
Bard Declares Quarterly Dividend 9-Dec-2009
Bard to Host December 2009 Investor Conference 16-Nov-2009
Bard Announces Third Quarter Results 21-Oct-2009
Bard Declares Quarterly Dividend 14-Oct-2009
Bard to Host Earnings Conference Call on October 21, 2009 14-Oct-2009
Court Rules in Favor of Bard in Class Action Lawsuit 29-Sep-2009
10b5-1(c) Trading Plan Announcement - Website Distribution Only 14-Aug-2009
Bard Announces Second Quarter Results 22-Jul-2009
Bard to Host Earnings Conference Call on July 22, 2009 15-Jul-2009
Bard Increases Quarterly Dividend 10-Jun-2009
Bard Announces First Quarter Results 22-Apr-2009
Bard Declares Quarterly Dividend 15-Apr-2009
Bard Announces $500 Million Share Repurchase Authorization 15-Apr-2009
Bard to Host Earnings Conference Call on April 22, 2009 15-Apr-2009
Bard Promotes Jim C. Beasley to Group Vice President 13-Apr-2009
Bard Receives FDA Approval for the LifeStent(R) Vascular Stent 17-Feb-2009
Bard Announces Fourth Quarter Results Revenue up 9 Percent as Reported, 12 Percent Excluding Foreign Exchange 29-Jan-2009
Bard to Host Earnings Conference Call on January 29, 2009 22-Jan-2009
Bard Declares Quarterly Dividend 10-Dec-2008
Bard Receives FDA Approval for the E*Luminexx(TM) Vascular Stent 8-Dec-2008
Bard to Host December 2008 Investor Conference 2-Dec-2008
10b5-1(c) Trading Plan Announcement - Website Distribution Only 2-Dec-2008
Bard Receives FDA Approval for the Flair(TM) Endovascular Stent Graft 29-Oct-2008
Bard Announces Third Quarter Results 22-Oct-2008
Bard to Host Earnings Conference Call on October 22, 2008 15-Oct-2008
Bard Declares Quarterly Dividend 8-Oct-2008
JAMA Publishes Study Results on Efficacy of the Bard Agento(R) I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia 20-Aug-2008
Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates 30-Jul-2008
Bard Announces Second Quarter Results 23-Jul-2008
Bard to Host Earnings Conference Call on July 23, 2008 16-Jul-2008
Bard Promotes Sharon M. Alterio to Group Vice President 25-Jun-2008
Bard Increases Quarterly Dividend 11-Jun-2008
Bard Closes Transaction to Acquire Specialized Health Products International, Inc. 6-Jun-2008
Bard Announces First Quarter Results 23-Apr-2008
Bard Declares Quarterly Dividend 16-Apr-2008
Bard to Host Earnings Conference Call on April 23, 2008 15-Apr-2008
Bard Signs Agreement to Acquire Specialized Health Products International, Inc. 10-Mar-2008
Bard Announces Fourth Quarter Results 31-Jan-2008
Bard to Host Earnings Conference Call on January 31, 2008 18-Jan-2008
Bard Closes Transaction to Acquire LifeStent(R) from Edwards Lifesciences 14-Jan-2008
Bard to License Hernia Product and Technology from Genzyme Corporation 17-Dec-2007
Bard Declares Quarterly Dividend 12-Dec-2007
Bard Announces Patent Infringement Verdict against W. L. Gore & Associates 12-Dec-2007
Bard Signs Agreement to Acquire LifeStent(R) from Edwards Lifesciences 7-Dec-2007
Bard to Host December 2007 Investor Conference 5-Dec-2007
Bard Receives Clearance to Market Agento(TM) IC Silver-Coated Endotracheal Tube 8-Nov-2007
Bard Announces Third Quarter Results 23-Oct-2007
Bard to Host Earnings Conference Call on October 23, 2007 16-Oct-2007
Bard Announces $500 Million Share Repurchase Authorization 10-Oct-2007
Bard Declares Quarterly Dividend 10-Oct-2007
Bard Announces Second Quarter Results 24-Jul-2007
Bard to Host Earnings Conference Call on July 24, 2007 17-Jul-2007
Bard Promotes John A. DeFord, Ph.D., to Senior Vice President, Science, Technology and Clinical Affairs 21-Jun-2007
Bard Increases Quarterly Dividend 13-Jun-2007
Bard Announces First Quarter Results 24-Apr-2007
Bard Declares Quarterly Dividend 18-Apr-2007
Bard to Host Earnings Conference Call on April 24, 2007 17-Apr-2007
C. R. Bard Marks Centennial in 2007 12-Apr-2007
Bard Appoints James M. Howard II as Vice President, Regulatory Sciences 12-Mar-2007
Bard Promotes Stephen J. Long to Vice President, General Counsel and Secretary 20-Feb-2007
Bard Announces Fourth Quarter Results 25-Jan-2007
Bard to Host Earnings Conference Call on January 25, 2007 18-Jan-2007
Bard Declares Quarterly Dividend 13-Dec-2006
Bard to Host December 2006 Investor Conference 4-Dec-2006
Bard Announces Third Quarter Results 18-Oct-2006
Bard Declares Quarterly Dividend 11-Oct-2006
Bard to Host Earnings Conference Call on October 18, 2006 11-Oct-2006
Bard Announces Second Quarter Results; Revenue up 11 Percent as Reported, 12 Percent Excluding Foreign Exchange 19-Jul-2006
Bard to Host Earnings Conference Call on July 19, 2006 12-Jul-2006
Bard Increases Quarterly Dividend 14-Jun-2006
10b5-1(c) Trading Plan Announcement - Website Distribution Only 21-Apr-2006
Bard Declares Quarterly Dividend 19-Apr-2006
Bard Announces First Quarter Results; Revenue up 9 Percent as Reported, 11 Percent in Constant Currency 18-Apr-2006
Bard to Host Earnings Conference Call on April 18, 2006 11-Apr-2006
Bard Completes Acquisition of Venetec International, Inc. 10-Apr-2006
Bard Concludes Enrollment in Infection Control Endotracheal Tube Trial 3-Mar-2006
Bard Signs Agreement to Acquire Venetec International, Inc. 1-Mar-2006
Bard Announces Fourth Quarter Results; Earnings Per Share up 15 Percent 25-Jan-2006
Bard to Host Earnings Conference Call on January 25, 2006 18-Jan-2006
Bard Acquires New Stent Technology 18-Jan-2006
Bard Announces Recall of Composix(R) Kugel(R) Mesh X-Large Patch 13-Jan-2006
Bard Announces $500 Million Share Repurchase Authorization 16-Dec-2005
Bard Declares Quarterly Dividend 14-Dec-2005
Bard to Host December 2005 Investor Conference 1-Dec-2005
Bard Announces Third Quarter Results 18-Oct-2005
Bard Declares Quarterly Dividend 12-Oct-2005
Bard to Host Earnings Conference Call on October 18, 2005 11-Oct-2005
Tommy G. Thompson Elected to Bard's Board of Directors 16-Aug-2005
Bard Announces Second Quarter Results 19-Jul-2005
Bard to Host Earnings Conference Call on July 19, 2005 12-Jul-2005
Bard Increases Quarterly Dividend 8-Jun-2005
Bard Declares Quarterly Dividend 20-Apr-2005
John H. Weiland Elected to Bard's Board of Directors; Former Chairman, President and CEO William H. Longfield Retires from Board 20-Apr-2005
Bard Announces First Quarter Results 19-Apr-2005
Bard to Host Earnings Conference Call on April 19, 2005 12-Apr-2005
Bard Updates First Quarter Guidance 16-Mar-2005
Bard's CEO to Speak at the SG Cowen & Co. 25th Annual Health Care Conference 11-Mar-2005
C. R. Bard earnings release issued prematurely 26-Jan-2005
Bard Exceeds Fourth Quarter Earnings Expectations; Earnings Per Share at 65 Cents 26-Jan-2005
Bard to Host Earnings Conference Call on January 26, 2005 19-Jan-2005
Bard Acquires Certain Assets of Genyx Medical 12-Jan-2005
Bard Declares Quarterly Dividend 10-Dec-2004
Bard to Host December 2004 Investor Conference 1-Dec-2004
Bard Reports Third Quarter Results; Net Sales up 17 Percent, 15 Percent on Constant Currency Basis 19-Oct-2004
Bard Names Judith A. Reinsdorf Vice President, General Counsel and Corporate Secretary 15-Oct-2004
Bard Declares Quarterly Dividend 13-Oct-2004
Bard to Host Earnings Conference Call on October 19, 2004 12-Oct-2004
Bard Closes Sale of Endoscopic Assets 1-Oct-2004
Bard to Divest Endoscopic Assets 18-Aug-2004
Bard Reports Second Quarter Results; Net Sales up 15 Percent on Constant Currency Basis 20-Jul-2004
Gail K. Naughton, Ph.D., Elected to Bard's Board of Directors 14-Jul-2004
Bard Increases Quarterly Dividend 14-Jul-2004
Bard to Host Earnings Conference Call on July 20, 2004 13-Jul-2004
Bard Acquires Hernia Repair Fixation System 1-Jul-2004
June is National Hernia Awareness Month; Innovative, Minimally Invasive Technique Speeds Procedure and Recovery Time 1-Jun-2004
Bard Declares Quarterly Dividend and Announces Two-For-One Stock Split 21-Apr-2004
Bard Reports First Quarter Results; Net Sales Up 13 Percent On Constant Currency Basis 20-Apr-2004
Bard to Host Earnings Conference Call on April 20, 2004 13-Apr-2004
Bard Updates First Quarter Guidance 9-Mar-2004
Bard Reports Fourth Quarter Results; Sales up 11 Percent on Constant Currency Basis 28-Jan-2004
Bard to Host Earnings Conference Call on January 28, 2004 21-Jan-2004
Bard Names New VP of Science & Technology 20-Jan-2004
Bard Declares Quarterly Dividend 10-Dec-2003
Bard to Host December 2003 Investor Conference 2-Dec-2003
Bard Launches Enhanced Corporate Web Site; Valuable Tool and Information Resource for Investors, Customers, & Patients 27-Oct-2003
Bard Reports Third-Quarter Results Net Sales up 12%, Earnings Per Share at 98 Cents 15-Oct-2003
Theodore E. Martin Elected To Bard's Board Of Directors 9-Oct-2003
Bard to Host Earnings Conference Call on October 15, 2003 8-Oct-2003
Bard Declares Quarterly Dividend 8-Oct-2003
Bard Receives Clearance to Market Removable Vena Cava Filter 12-Aug-2003
Bard Succession Plan Complete 8-Aug-2003
Bard Acquires Vacuum-Assisted Biopsy Device 24-Jul-2003
Bard Reports Second Quarter Results; Earnings up 13%, Sales Up 12% 16-Jul-2003
Bard to Host Earnings Conference Call on July 16, 2003 9-Jul-2003
Bard Increases Quarterly Dividend 9-Jul-2003
Bard Receives Clearance to Market HemoSplit Dialysis Catheter 8-Jul-2003
Bard Announces Introduction of Fluent Constant Flow Pump in Europe 23-Jun-2003
Bard Acquires Source Tech Medical 16-Jun-2003
ADVISORY/Live Webcast Showcasing Bard's Innovative, Minimally-Invasive Procedure To Treat Chronic Heartburn Sufferers 2-May-2003
Bard Names Group Vice Presidents 29-Apr-2003
Bard Declares Quarterly Dividend 16-Apr-2003
Bard Exceeds First Quarter Expectations; Earnings Per Share at 89 Cents 15-Apr-2003
Bard Names Scott T. Lowry Vice President And Treasurer 9-Apr-2003
Bard Names Eric J. Shick Vice President- Investor Relations 7-Apr-2003
Bard to Host Spring 2003 Investor Conference 4-Apr-2003
Bard Names Todd C. Schermerhorn Senior Vice President and Chief Financial Officer 28-Feb-2003
Bard Files Suit Under Pourchez Patent 19-Feb-2003
Multimedia Available: Bard Board Approves Succession Plan: Timothy M. Ring to Succeed William H. Longfield as Chairman and CEO 13-Feb-2003
Bard Board Approves Succession Plan: Timothy M. Ring to Succeed William H. Longfield as Chairman and CEO; John H. Weiland to Become President and COO 13-Feb-2003
Bard Exceeds Fourth Quarter Expectations - Earnings Per Share at $.89 28-Jan-2003
Bard Announces Agreement to Acquire Genyx Medical 24-Jan-2003
Bard to Host Earnings Conference Call on January 28, 2003 21-Jan-2003
Bard Announces New Technology To Revolutionize Umbilical Hernia Repair 3-Jan-2003
Bard Provides Financial Guidance for 2003; Company Reaffirms Fourth Quarter 2002 Guidance 13-Dec-2002
Bard Announces 5 Million Share Purchase Authorization 12-Dec-2002
Bard Declares Quarterly Dividend 11-Dec-2002
Bard to Host Guidance Conference Call On December 13, 2002 10-Dec-2002
Recent Media Report On Bard Succession Plan Erroneous 21-Oct-2002
Bard Exceeds Third Quarter Earnings Expectations - EPS of $0.85 Per Share Before Non-Recurring Items 16-Oct-2002
Bard to Host Earnings Conference Call On October 16, 2002 9-Oct-2002
Bard Declares Quarterly Dividend 9-Oct-2002
Bard's CEO To Speak At Bear Stearns' 15th Annual Healthcare Conference 11-Sep-2002
Bard Announces Issuance Of ePTFE Vascular Patent 20-Aug-2002
Bard Taps Washington Veteran 18-Jul-2002
Consistent Sales Growth Drives Bard's Second Quarter EPS 17-Jul-2002
Bard Increases Quarterly Dividend 10-Jul-2002
Bard To Host Earnings Conference Call 10-Jul-2002
June is National Hernia Month 3-Jun-2002
Herbert L. Henkel Elected To Bard's Board Of Directors 19-Apr-2002
Bard Reports First Quarter Results in Line with Guidance 17-Apr-2002
Bard Declares Quarterly Dividend 17-Apr-2002
Bard Will Host Spring 2002 Investor Conference 12-Apr-2002
Bard To Host Earnings Conference Call On April 16, 2002 8-Apr-2002
Bard Provides Financial Guidance For 2002 8-Feb-2002
Bard and Tyco Terminate Merger Agreement 6-Feb-2002
Bard Reports Fourth Quarter Results 29-Jan-2002
Bard Evaluates Tyco Announcement 23-Jan-2002
Bard Declares Quarterly Dividend 12-Dec-2001
Bard's Endocinch™ Device For Chronic Heartburn Receives New Medicare Reimbursement Code 10-Dec-2001
10-Q Filing Disclosures 15-Nov-2001
Bard Reports Third Quarter Results 17-Oct-2001
Bard Declares Quarterly Dividend 10-Oct-2001
Bard Shareholders approve merger with Tyco 7-Aug-2001
Bard Reports Second Quarter Results 17-Jul-2001
Bard Declares Quarterly Dividend 11-Jul-2001
Bard receives approval for Advanced Ablation Catheter 28-Jun-2001